Compare MINISO Group Holding Ltd (MNSO) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MINISO Group Holding Ltd vs Smith & Nephew plc — how do they compare? MINISO Group Holding Ltd trades at $9.14 (market cap $2.81B), while Smith & Nephew plc trades at $27.72 (market cap $11.63B). The key difference: Smith & Nephew plc is far larger — about 4.1× MINISO Group Holding Ltd's market cap, and MINISO Group Holding Ltd pays the higher dividend (7.12%). Which is the better fit depends on your goals.
| MNSO | SNN | |
|---|---|---|
Market Cap | $2.81B | $11.63B |
Sector | Technology | Health |
52-Week High | $25.31 | $38.53 |
52-Week Low | $9.23 | $27.80 |
Enterprise Value | $3.68B | $14.66B |
Dividend Yield | 7.12% | 2.85% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MNSO trades at $9.36, down 2.09% today, with mixed technical signals showing bearish moving averages but bullish oscillators including oversold RSI levels. Fundamentally, the company reported strong Q1 2026 earnings beat but missed expectations in three of the last four quarters. Revenue grew 22.4% YoY in H1 2026 to RMB 11.5 billion, driven by domestic China performance and store expansion, though overseas markets showed weakness. The company announced a HK$2 billion share repurchase program in June 2026 to support shareholder value.
The stock presents a value opportunity with attractive valuation multiples (P/E 15.25, P/S 0.82) below industry averages, supported by 60% analyst buy ratings and $11.05 consensus price target offering 18% upside. However, inconsistent earnings performance, competitive retail pressures, and overseas execution risks warrant caution. The oversold technical condition suggests potential near-term rebound potential if fundamental improvements materialize.
Smith & Nephew (SNN) trades at $27.87, down 3.46% over 24 hours and near its 52-week low. The stock shows a bearish technical trend with mixed sentiment; recent earnings have mostly beaten expectations, but Q2 2026 revenue growth missed and guidance was cut. Fundamentals are solid with revenue rising to $6.16B in 2025 and net income margin improving to 10.08%, though debt levels have increased. The company faces competitive pressures in key markets like U.S. Orthopaedics.
Outlook is cautious: valuation ratios like P/E of 18.96 are reasonable, but analyst consensus is Hold (65%) due to execution risks and CFO departure. Opportunities include innovation in surgical robotics and new product launches, but investors should monitor U.S. market weakness and debt management for sustained recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About MINISO Group Holding Ltd
MINISO Group Holding Ltd is a global lifestyle product retailer known for its aesthetically pleasing, high-quality, and low-cost goods. The company operates a network of branded stores worldwide, offering a diverse range of merchandise, including household goods, cosmetics, toys, and digital accessories. MINISO's business model emphasizes rapid product iteration, efficient supply chain management, and a joint venture and franchise partner network to facilitate its global expansion.
Read more on MNSO →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
